ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Comprehensive analysis: Necroptosis-related lncRNAs can effectively predict the prognosis of glioma patients

Chen, Desheng; Dou, Chao; Liu, Haiyu; Xu, Binshun; Hu, Bowen; Kuang, Liangwen; Yao, Jiawei; Zhao, Yan; Yu, Shan; Li, Yang; Wang, Fuqing*; Guo, Mian*哈尔滨医科大学
Frontiers in Oncology2022-8-10DOI: 10.3389/fonc.2022.929233
4被引6阅读
引用收藏
分享

摘要

Glioma is the most common and fatal primary brain tumor in humans. A significant role for long non-coding RNA (lncRNA) in glioma is the regulation of gene expression and chromatin recombination, and immunotherapy is a promising cancer treatment. Therefore, it is necessary to identify necroptosis-related lncRNAs in glioma. In this study, we collected and evaluated the RNA-sequencing (RNA-seq) data from The Cancer Genome Atlas (TCGA, https://www.ncbi.nlm.nih.gov/, Data Release 32.0, March 29, 2022) glioma patients, and necroptosis-related lncRNAs were screened. Cox regression and least absolute shrinkage and selection operator (LASSO) analysis were performed to construct a risk score formula to explore the different overall survival between high- and low-risk groups in TCGA. Gene Ontology (GO) and pathway enrichment analysis (Kyoto Encyclopedia of Genes and Genomes (KEGG)) were performed to identify the function of screened genes. The immune correlation analysis showed that various immune cells and pathways positively associated with a patient's risk score. Furthermore, the analysis of the tumor microenvironment indicated many immune cells and stromal cells in the tumor microenvironment of glioma patients. Six necroptosis-related lncRNAs were concerned to be involved in survival and adopted to construct the risk score formula. The results showed that patients with high-risk scores held poor survival in TCGA. Compared with current clinical data, the area under the curve (AUC) of different years suggested that the formula had better predictive power. We verified that necroptosis-related lncRNAs play a significant role in the occurrence and development of glioma, and the constructed risk model can reasonably predict the prognosis of glioma. The results of these studies added some valuable guidance to understanding glioma pathogenesis and treatment, and these necroptosis-related lncRNAs may be used as biomarkers and therapeutic targets for glioma prevention.

学科与关键词

关键词
gliomasimmuneTEMbiomarkernecroptosis-related lncRNAs
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Frontiers in Oncology
发表日期
2022-08-10
卷期
第 12 卷
页码
929233
DOI
10.3389/fonc.2022.929233
期刊等级
3区
成果收录
SCIE
资助标注
National Natural Science Foundation of China; [82173384]; [81773161]

作者

  • C

    Chen, Desheng (第一作者)

    2 · harbin med univ

  • D

    Dou, Chao

    2 · harbin med univ

查看全部 12 位作者收起作者
  • L

    Liu, Haiyu

    2 · harbin med univ

  • X

    Xu, Binshun

    2 · harbin med univ

  • H

    Hu, Bowen

    2 · harbin med univ

  • K

    Kuang, Liangwen

    2 · harbin med univ

  • Y

    Yao, Jiawei

    2 · harbin med univ

  • Z

    Zhao, Yan

    2 · harbin med univ

  • Y

    Yu, Shan

    2 · harbin med univ

  • L

    Li, Yang

    2 · harbin med univ

  • W

    Wang, Fuqing (通讯)

  • G

    Guo, Mian (通讯)

    2 · harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417